833 High-Dose Recombinant Interferon-Α1b: An Effective Immunotherapy With Low Toxicity for Melanoma Patients

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.909
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Interferon Signaling Patterns in Peripheral Blood Lymphocytes May Predict Clinical Outcome After High-Dose Interferon Therapy in Melanoma Patients

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Low-Dose Methotrexate Toxicity

CMAJ
Medicine
2019English

Low-Dose Splenic Irradiation Is Effective for Patients With Hematological Diseases Who Have Symptomatic Splenomegaly

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Evaluating the Efficacy of Low Dose Dexmedetomidine With Low Dose Bupivacaine as an Adjuvant for Lower Limb Surgery in Elderly and High Risk Patients

Journal of Evolution of Medical and Dental Sciences
2015English

Effective Melanoma Immunotherapy With Interleukin-2 Delivered by a Novel Polymeric Nanoparticle

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Combination Immunotherapy for Melanoma

JAMA Oncology
Cancer ResearchOncology
2015English

Amphotericin B for Cryptococcal Meningitis in HIV Positive Patients: Low Dose Versus High Dose

Indian Journal of Critical Care Medicine
Critical CareIntensive Care Medicine
2007English

High-Dose Glucocorticoids for the Treatment of Ipilimumab-Induced Hypophysitis Is Associated With Reduced Survival in Patients With Melanoma

Cancer
Cancer ResearchOncology
2018English

Advances in Immunotherapy for Melanoma

BMC Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy